A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease
Clinical trial NCT07758595 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07758595
- Sponsor
- Denali Therapeutics Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2030-04-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.